Use of the Membrane Filtration Technique and Staib Agar* for the Detection of Cryptococcus neoformans in the Urine of AIDS Patients —A Contribution to Diagnosis, Therapy and Pathogenesis of Cryptococcosis
- 1 February 1989
- Vol. 32 (2) , 63-72
- https://doi.org/10.1111/j.1439-0507.1989.tb02203.x
Abstract
For the cultural control of Cryptococcus neoformans (Cr.n.), among the routinely examined standard specimens like CSF, sputum, blood, etc., urine earns special attention. The combination of membrane filtration technique (MFT) and Staib agar for the detection of Cr.n. from body fluids as described by Staib in 1973 was used for the cultural isolation of Cr.n. from urine of AIDS patients. In 3 examplary cases the diagnostic significance of this method could be demonstrated: The brown colour effect (BCE) of Cr.n. of a single CFU, as well as in colonies growing with a high density, was produced on average within 3-5 d/26.degree. C. The method was found to be useful for the evaluation of antimycotic therapy. One example of the survival of a few CFUs of Cr.n. under treatment with fluconazole as compared to the efficacy of therapy with amphotericin B + flucytosine, and one example of a re-emergence of Cr.n. in the urogenital tract after a too short duration of treatment with amphotericin B + flucytosine are shown. For the exclusion of the survival of single CFUs of Cr.n. in the urogenital tract of males, quantities up to 1 l of urine for the combination of MFT and Staib agar are proposed. As a secondary observation it was found that this diagnostic combination in addition to its primary purpose, can serve to detect the metabolic end products of the human body present in urine which may influence capsule formation of Cr. neoformans.Keywords
This publication has 12 references indexed in Scilit:
- Mycological-Diagnostic Assessment of the Efficacy of Amphotericin B + Flucytosine to Control Cryptococcus neoformans in AIDS Patients*/Mykologisch-diagnostische Beurteilung der Wirksamkeit von Amphotericin B + Flucytosin gegen Cryptococcus neoformans beiMycoses, 2009
- Soluble Polysaccharides of Cryptococcus neoformansPublished by Springer Nature ,1988
- Treatment of Cryptococcal Meningitis with Combination Amphotericin B and Flucytosine for Four as Compared with Six WeeksNew England Journal of Medicine, 1987
- The brown colour effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patientsZentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology, 1987
- Prostatic cryptococcosis in acquired immune deficiency syndromeUrology, 1986
- Pharmacokinetics of amphotericin B and flucytosinePublished by Oxford University Press (OUP) ,1979
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979
- Identification of Cryptococcus Species in the Diagnostic LaboratoryAmerican Journal of Clinical Pathology, 1971
- Membranfiltration und Negersaat (Gruizotia abyssinica)-Nährboden für den Cryptococcus neoformans-Nachweis (Braunfarbeffekt)Medical Microbiology and Immunology, 1963
- Cyptococcus neoformans und Guizotia abyssinica (syn. G. oleifera D. C.)Medical Microbiology and Immunology, 1962